We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AVO Advanced Oncotherapy Plc

0.00 (0.0%)
01 Dec 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Oncotherapy Plc LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 1.925 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories -29.49M -0.0549 -0.35 10.32M
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 1.925 GBX

Advanced Oncotherapy (AVO) Latest News

Advanced Oncotherapy (AVO) Discussions and Chat

Advanced Oncotherapy (AVO) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Advanced Oncotherapy (AVO) Top Chat Posts

Top Posts
Posted at 02/12/2023 08:20 by Advanced Oncotherapy Daily Update
Advanced Oncotherapy Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker AVO. The last closing price for Advanced Oncotherapy was 1.93p.
Advanced Oncotherapy currently has 537,481,209 shares in issue. The market capitalisation of Advanced Oncotherapy is £10,319,639.
Advanced Oncotherapy has a price to earnings ratio (PE ratio) of -0.35.
This morning AVO shares opened at -
Posted at 30/11/2023 22:23 by daijavu
I think we all have to take a lesson from this.

Never invest in a share just because of the story.
Posted at 02/10/2023 07:48 by daijavu
There's hope for us yet. If AVO gets through this and there's a clear path to treating the first patient and confirming contracts, the share price could shoot up.
Posted at 30/9/2023 07:01 by waterloo01
Goodness a long time and way from looking at the building site in Harley St and realizing they were never going to make their initial dates.

waterloo01 - 01 Mar 2023 - 18:57:17 - 4971 of 5061 Advanced Oncotherapy (AVO) - formerly CareCapital - AVO
twirl, I think you called me 'altruistic' back in 2017 when I suggested all was far from well. Seems the same is true today. Wrong management. Scientists! (and still not open)

waterloo01 - 18 Jul 2017 - 18:29:56 - 3522 of 4971 Advanced Oncotherapy (AVO) - formerly CareCapital - AVO
Wrong people running this as has been the case for a long time. Good science/bad business. Evans wasn't the 1st red flag but the video of the demolition block, might be the last before the inevitable. To think they raised at £1.00 not that long ago. At least the BOD are also heavily invested.
Posted at 20/6/2023 15:01 by daijavu
The main thing that keeps me invested is the technology. The main thing that worries me is the BoD.

The finances shouldn't bother anyone that much because the technology is so valuable that it should outweigh all other considerations and make AVO a must have company to invest in.

Unfortunately, the company and investors have been let down by the BoD so often over the 10 years I've been watching AVO, and in and out of holding the shares, that it's no surprise to me that AVO is now in the situation it's in.

I'm waiting until the risk of it going into administration is out of the way before I put any more 'real money' in.
Posted at 28/3/2023 07:00 by daijavu
From how AVO seems to work, they outsource production. They don't make many, or any, components themselves. What they've done up to now is focus on the final assembly. That means that volume ought not to be an issue. Cost could be taken care of by building to order, in which case the purchasers pay the costs of production before they get the machine. AVO have already calculated the selling price and their anticipated profit so I assume the difference is their anticipated cost of production. To get to those figures they must have agreements in place in which the manufacturers of the components provide AVO with their cost of production figures. AVO doesn't have any factories outside of Daresbury because they won't need them.

They seem to be planning to be an asset light company, a bit like Apple and Microsoft who don't actually make anything themselves. They outsource everything and get paid a lot of money for selling it all to you and me.

I anticipate that AVO might be similar. All they need to do now is get over their present financial difficulties.
Posted at 27/3/2023 07:37 by daijavu
red hook.
While I'm not impressed by the BoD, I hope you're wrong. The AVO share price has been here before but AVO survived.

It's an unusually tight spread this morning and the first trades are buys
Posted at 26/3/2023 18:43 by red rook
... not a holder here, but have been following events over the years
... agree the technology is great but certainly not the BoD
... would appear they are intentionally driving AVO into the ground
... it will be picked up cheap in a fire sale, or after administration

... regarding ''if AVO folds, ... be unfortunate for AVO shareholders and for the scientific members of the AVO BoD''

... no need to worry about the BoD :-)
... on AIM, not all shareholders are created equal, irrespective of what the rules say
... it will certainly be unfortunate for the retail shareholders
... but the BoD will negotiate themselves a good deal what ever happens, or whoever takes over.
... it's a shame but that's the reality
... maybe that's why the BoD appear to be so laid back about the unfolding train crash
Posted at 26/3/2023 00:49 by daijavu
Most of the risk has now been removed and we are close to AVO making money. My main concern is that while LIGHT will undeniably be a success it might not be with AVO.

I believe that CERN still holds the rights to LIGHT so that if AVO folds, LIGHT could be licenced by CERN to another company. That would be unfortunate for AVO shareholders and for the scientific members of the AVO BoD who helped develop LIGHT from its early days under CERN a decade or more ago. Before AVO existed.

My view is that LIGHT makes AVO different from most other AIM companies and CERN's interest in LIGHT makes it more different still.

But what do I know?
Posted at 01/3/2023 11:10 by gerhart
At end of Dec most/all key directors bought shares around 12p. Just a few weeks later they issue financial plans. Share price goes on major slide.

So did the directors buy, knowing any placing/rights (along with any financial loans) will be well above 12p.

Or did they buy to give the impression, that they were suffering too, knowing share price would take a hit on speculation once the plans were announced - which they must have known general intentions when they bought.

I think and hope it is the former. All those big investors that stumped up big sums previously must have known the long term risk/plans for final funds to bring Tech to fruition. So wouldn't have stumped-up just to watch their investment collapse.

So this share price slide is due to negative speculation only? That's my hope.

(happened, justifiably, before when they got into the death spiral shares for loans. Shares dumped. Price fell. Even greater shares for loans. Shares dumped, price fell...etc etc. Then they changed track, and their was massive spike)
Posted at 03/8/2022 08:09 by daijavu
Does anyone remember AVO's massive reverse split of 2016?

The share price had been hovering around 20p for quite a while when the BoD announced their brilliant plan to make the share price 'easier to understand'. They cut everyone's share holding by 25 times. so that if you owned, say, 1,000 shares before the reverse split, you suddenly owned just 40 shares after it. But the share price immediately went up to £5 a share so you didn't lose any money. Not at first. The BoD then went on to gradually increase the number of shares through fund raisings, causing massive dilutions that have brought the share price back down to around 20p.

I wonder what they'll do next?
Advanced Oncotherapy share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |